Abstract

BackgroundThe triglyceride-glucose (TyG) index is a marker of insulin resistance (IR) and has been associated with various metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases. However, limited information is available regarding its association with subclinical cerebral small vessel disease (cSVD). In this study, we evaluated the relationship between the TyG index and cSVD, including silent brain infarcts (SBIs) and white matter hyperintensity (WMH).MethodsWe assessed health check-up participants aged 40–79 years from 2006 to 2013. The TyG index was calculated using the log scale of fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2. The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was also calculated. This was compared with two insulin surrogates and cSVD as another IR indicator and compared the association between two insulin surrogates and cSVD. SBI was measured for both prevalence and burden. The WMH volume was quantitatively rated using a computer-assisted semi-automated technique.ResultsA total of 2615 participants were evaluated (median age: 56 years, male sex: 53%). In the multivariable logistic regression analysis, the TyG index was seen to be associated with SBI prevalence (adjusted odds ratio: 1.39; 95% confidence interval [CI] = 1.06–1.81). Further quantitative analyses showed a positive dose–response relationship between the TyG index and SBI burden (P for trend = 0.006). In multivariable linear regression analysis, the TyG index was also found to be related to the volume of WMH (β = 0.084; 95% CI = 0.013 to 0.154). Additionally, the TyG index showed a similar or slightly stronger association with the prevalence of SBI and the volume of WMH than did HOMA-IR.ConclusionsA high TyG index was associated with a higher prevalence and burden of cSVD in a neurologically healthy population. This marker of IR could be a convenient and useful predictor of cSVD.

Highlights

  • The triglyceride-glucose (TyG) index is a marker of insulin resistance (IR) and has been associated with various metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases

  • It was found that the presence of Silent brain infarct (SBI) was related to age, use of antihypertensives and antiplatelet agents, systolic and diastolic blood pressure (BP), level of HbA1c, fasting glucose, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), total/low-density lipoprotein (LDL)/high-density lipoprotein (HDL) cholesterol, TG, high-sensitivity C-reactive protein (hs-CRP), and the TyG index (Table 1)

  • In the multivariable logistic regression analyses, the TyG index was found to be significantly associated with SBI after adjusting for confounders

Read more

Summary

Introduction

The triglyceride-glucose (TyG) index is a marker of insulin resistance (IR) and has been associated with various metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases. We evaluated the relationship between the TyG index and cSVD, including silent brain infarcts (SBIs) and white matter hyperintensity (WMH). Insulin resistance (IR) is a pathological condition that results from poor insulin sensitivity in the peripheral tissues [1]. IR increases the risk of metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases. It is necessary to accurately measure IR in clinical practice [1,2,3,4,5]. The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) has been proposed. The HOMA-IR requires insulin levels that are not usually measured in clinical practice [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call